Solid lipid nanoparticles enhance oral bioavailability of resveratrol, a natural polyphenol

Food Research International

Volumn 62, Issue , 2014, Pages 1165-1174

  Pandita, Deepti ^a   Kumar, Sandeep ^a   Poonia, Neelam ^a   Lather, Viney ^a  

^a Jan Nayak Ch Devi Lal Memorial College of Pharmacy   (India)

Author keywords

Bioavailability; Oral delivery; Pharmacokinetic study; Resveratrol; Solid lipid nanoparticles; Stearic acid

Indexed keywords

BIOCHEMISTRY; DRUG PRODUCTS; ENCAPSULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NANOPARTICLES; STEARIC ACID;

BIOAVAILABILITY; ENCAPSULATION EFFICIENCY; ORAL DELIVERY; PHARMACOKINETIC PARAMETERS; PHARMACOKINETIC STUDIES; REVERSE PHASE HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; SOLID LIPID NANOPARTICLE (SLN); SOLID LIPID NANOPARTICLES;

RESVERATROL;

EID: 84904619852     PISSN: 09639969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.foodres.2014.05.059     Document Type: Article

References (36)

1. Amri A., Chaumeil J.C., Sfar S., Charrueau C. Administration of resveratrol: What formulation solutions to bioavailability limitations?. Journal of Controlled Release 2012, 158(2):182-193.
2. Ansari K.A., Vavia P.R., Trotta F., Cavalli R. Cyclodextrin-based nanosponges for delivery of resveratrol: In vitro characterisation, stability, cytotoxicity and permeation study. AAPS PharmSciTech 2011, 12(1):279-286.
3. Cai S., Yang Q., Bagby T.R., Forrest M.L. Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles. Advanced Drug Delivery Reviews 2011, 63(10-11):901-908.
4. Carlotti M.E., Sapino S., Ugazio E., Gallarate M., Morel S. Resveratrol in solid lipid nanoparticles. Journal of Dispersion Science and Technology 2011, 33(4):465-471.
5. Chinsriwongkul A., Chareanputtakhun P., Ngawhirunpat T., Rojanarata T., Sila-on W., Ruktanonchai U., et al. Nanostructured lipid carriers (NLC) for parenteral delivery of an anticancer drug. AAPS PharmSciTech 2012, 13(1):150-158.
6. Duchêne D., Ponchel G. Bioadhesion of solid oral dosage forms, why and how?. European Journal of Pharmaceutics and Biopharmaceutics 1997, 44(1):15-23.
7. Emília Juan M., Buenafuente J., Casals I., Planas J.M. Plasmatic levels of trans-resveratrol in rats. Food Research International 2002, 35(2-3):195-199.
8. Florence A.T. The oral absorption of micro- and nanoparticulates: Neither exceptional nor unusual. Pharmaceutical Research 1997, 14(3):259-266.
9. Harde H., Das M., Jain S. Solid lipid nanoparticles: An oral bioavailability enhancer vehicle. Expert Opinion on Drug Delivery 2011, 8(11):1407-1424.
10. Helen Chan O., Stewart B.H. Physicochemical and drug-delivery considerations for oral drug bioavailability. Drug Discovery Today 1996, 1(11):461-473.
11. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W., et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997, 275(5297):218-220.
12. Juan M.E., Maijo M., Planas J.M. Quantification of trans-resveratrol and its metabolites in rat plasma and tissues by HPLC. Journal of Pharmaceutical and Biomedical Analysis 2010, 51(2):391-398.
13. Kreuter J. Peroral administration of nanoparticles. Advanced Drug Delivery Reviews 1991, 7(1):71-86.
14. Lin H.S., Ho P.C. A rapid HPLC method for the quantification of 3,5,4'-trimethoxy-trans-stilbene (TMS) in rat plasma and its application in pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis 2009, 49(2):387-392.
15. Lu X., Ji C., Xu H., Li X., Ding H., Ye M., et al. Resveratrol-loaded polymeric micelles protect cells from Abeta-induced oxidative stress. International Journal of Pharmaceutics 2009, 375(1-2):89-96.
16. Mehnert W., Mader K. Solid lipid nanoparticles: Production, characterization and applications. Advanced Drug Delivery Reviews 2001, 47(2-3):165-196.
17. Mukherjee K., Venkatesh M., Venkatesh P., Saha B.P., Mukherjee P.K. Effect of soy phosphatidyl choline on the bioavailability and nutritional health benefits of resveratrol. Food Research International 2011, 44(4):1088-1093.
18. Narayanan N.K., Nargi D., Randolph C., Narayanan B.A. Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice. International Journal of Cancer 2009, 125(1):1-8.
19. Ndiaye M., Kumar R., Ahmad N. Resveratrol in cancer management: Where are we and where we go from here?. Annals of the New York Academy of Sciences 2011, 1215:144-149.
20. Neves A.R., Lucio M., Martins S., Lima J.L., Reis S. Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability. International Journal of Nanomedicine 2013, 8:177-187.
21. O'Driscoll C.M. Lipid-based formulations for intestinal lymphatic delivery. European Journal of Pharmaceutics and Biopharmaceutics 2002, 15(5):405-415.
22. Pandita D., Ahuja A., Lather V., Benjamin B., Dutta T., Velpandian T., et al. Development of lipid-based nanoparticles for enhancing the oral bioavailability of paclitaxel. AAPS PharmSciTech 2011, 12(2):712-722.
23. Pandita D., Ahuja A., Lather V., Dutta T., Velpandian T., Khar R.K. Development, characterization and in vitro assessement of stearylamine-based lipid nanoparticles of paclitaxel. Pharmazie 2011, 66(3):171-177.
24. Pandita D., Ahuja A., Velpandian T., Lather V., Dutta T., Khar R.K. Characterization and in vitro assessment of paclitaxel loaded lipid nanoparticles formulated using modified solvent injection technique. Pharmazie 2009, 64(5):301-310.
25. Patel S., Chavhan S., Soni H., Babbar A.K., Mathur R., Mishra A.K., et al. Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route. Journal of Drug Targeting 2011, 19(6):468-474.
26. Priyanka K., Sathali A.A. Preparation and evaluation of montelukast sodium loaded solid lipid nanoparticles. Journal of Young Pharmacists 2012, 4(3):129-137.
27. Qian C., Decker E.A., Xiao H., McClements D.J. Impact of lipid nanoparticle physical state on particle aggregation and β-carotene degradation: Potential limitations of solid lipid nanoparticles. Food Research International 2013, 52(1):342-349.
28. Seeballuck F., Ashford M.B., O'Driscoll C.M. The effects of pluronics block copolymers and Cremophor EL on intestinal lipoprotein processing and the potential link with P-glycoprotein in Caco-2 cells. Pharmaceutical Research 2003, 20(7):1085-1092.
29. Shi G., Rao L., Yu H., Xiang H., Yang H., Ji R. Stabilization and encapsulation of photosensitive resveratrol within yeast cell. International Journal of Pharmaceutics 2008, 349(1-2):83-93.
30. Souto E.B. Applications of lipid nanoparticles (SLN and NLC) in food industry. Journal of Food Technology 2006, 4(1):90-95.
31. Teskac K., Kristl J. The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol. International Journal of Pharmaceutics 2010, 390(1):61-69.
32. Walle T. Bioavailability of resveratrol. Annals of the New York Academy of Sciences 2011, 1215:9-15.
33. Wang X.F., Zhang S.L., Zhu L.Y., Xie S.Y., Dong Z., Wang Y., et al. Enhancement of antibacterial activity of tilmicosin against Staphylococcus aureus by solid lipid nanoparticles in vitro and in vivo. The Veterinary Journal 2012, 191(1):115-120.
34. Wong H.L., Bendayan R., Rauth A.M., Li Y., Wu X.Y. Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles. Advanced Drug Delivery Reviews 2007, 59(6):491-504.
35. Wu C.F., Yang J.Y., Wang F., Wang X. Resveratrol: Botanical origin, pharmacological activity and applications. Chinese Journal of Natural Medicines 2013, 11(1):1-15.
36. Xie S., Pan B., Wang M., Zhu L., Wang F., Dong Z., et al. Formulation, characterization and pharmacokinetics of praziquantel-loaded hydrogenated castor oil solid lipid nanoparticles. Nanomedicine (London, England) 2010, 5(5):693-701.